Exchange Traded Concepts’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-60,296
Closed -$426K 1336
2024
Q4
$426K Sell
60,296
-9,786
-14% -$77.9K 0.01% 809
2024
Q3
$570K Sell
70,082
-12,931
-16% -$93.4K 0.01% 734
2024
Q2
$530K Buy
83,013
+8,756
+12% +$56.2K 0.01% 694
2024
Q1
$559K Sell
74,257
-223
-0.3% -$2.04K 0.01% 642
2023
Q4
$690K Sell
74,480
-18,127
-20% -$148K 0.02% 488
2023
Q3
$937K Sell
92,607
-13,690
-13% -$163K 0.03% 405
2023
Q2
$1.33M Sell
106,297
-4,045
-4% -$48.2K 0.03% 333
2023
Q1
$1.29M Sell
110,342
-41,948
-28% -$535K 0.04% 286
2022
Q4
$1.62M Buy
152,290
+16,155
+12% +$156K 0.05% 218
2022
Q3
$1.32M Buy
136,135
+26,032
+24% +$345K 0.04% 208
2022
Q2
$1.59M Buy
110,103
+27,069
+33% +$461K 0.05% 200
2022
Q1
$2.17M Buy
83,034
+13,907
+20% +$395K 0.04% 215
2021
Q4
$2.74M Buy
69,127
+7,089
+11% +$323K 0.05% 210
2021
Q3
$3.1M Buy
62,038
+4,953
+9% +$270K 0.08% 179
2021
Q2
$3.17M Sell
57,085
-2,998
-5% -$160K 0.1% 162
2021
Q1
$2.81M Buy
60,083
+15,791
+36% +$765K 0.11% 146
2020
Q4
$1.93M Buy
44,292
+24,553
+124% +$906K 0.09% 149
2020
Q3
$722K Buy
+19,739
New +$670K 0.04% 207

Other funds holding HCAT